Skip to main content

Nebula Research & Development LLC

SEC CIK
0001792635
Latest filing
May 15, 2026

ENTA holding history

Enanta Pharmaceuticals Inc in every 13F filed by Nebula Research & Development LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ENTA overviewAll 13F holders of ENTAFull Q1 2026 holdings

Shares (Q2 2024)
0
Sold out in Q2 2024
Value
$0
% of portfolio
0.0%
Quarters held
2
Since Q4 2023
Holdings of ENTA by Nebula Research & Development LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20240$00.0%−15,745−100.0%Sold outHolders
Q1 202415,745$274.9K0.1%−2,723−14.7%ReducedHolders
Q4 202318,468$173.8K0.1%+18,468NewHolders